Chromai
PrivateLast Round
Strategic
Feb 24, 2026
Total Funding Raised
$22.98M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Chromai is a diagnostic equipment company that develops medical molecular diagnostics and testing technology.
Sector
Frontier & Industrial Tech
Verticals
Biotech Equipment, Computing Hardware, Environmental Monitoring, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chromai Comparables
Compare Chromai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dalian Elite Analytical Instruments Co., Ltd. | 83% | |
| Agilent Technologies | 69% | |
| PerkinElmer | 65% |
Chromai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Feb 24, 2026 | ||||
| Series A Extension | Aug 25, 2025 | ||||
| Series A | Jun 5, 2023 | ||||
| Seed | Dec 23, 2021 | ||||
| Pre Seed | Aug 23, 2021 | ||||
Angel | Mar 17, 2020 |
Chromai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| YuanBio Venture Capital | Series A |
| Oriza Ventures | Series A |
| Linear Capital | Angel |
| Huagai Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles increased to 13, 130% of current headcount.
- Jul 6, 2026
Open roles increased to 9, 82% of current headcount.
Chromai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Chromai's valuation, stock price, and market status.
Is Chromai a public or private company?
Chromai is a private company.
What is the current stock price of Chromai?
Chromai is a private company with no public stock price. No recent secondary market data is available.
How much is Chromai worth (valuation)?
Valuation information for Chromai is not publicly available.
Can I buy Chromai stock?
Chromai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Chromai's last funding round?
Chromai's most recent funding round was Series A on June 5, 2023.
Who are the main investors in Chromai?
Key investors in Chromai include Huagai Capital.
Will Chromai IPO soon?
No public IPO plans have been announced for Chromai.
How can I track Chromai secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Chromai's secondary market activity and sign up for updates.